Le produit a bien été ajouté au panier.

discount label
H-KAFDITYVRLKF-OH
Vue en 3D

Biosynth logo

H-KAFDITYVRLKF-OH

Ref. 3D-PP44225

1mg
263,00 €
10mg
312,00 €
100mg
518,00 €
Livraison estimée en/au États-Unis, le vendredi 27 décembre 2024

Informations sur le produit

Nom :
H-KAFDITYVRLKF-OH
Synonymes :
  • NH2-Lys-Ala-Phe-Asp-Ile-Thr-Tyr-Val-Arg-Leu-Lys-Phe-OH
Description :

Peptide H-KAFDITYVRLKF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KAFDITYVRLKF-OH include the following: Characterization of Novel Cell-Adhesive Peptides for Biomaterial Development Y Yamada - Biological and Pharmaceutical Bulletin, 2024 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/bpb/47/6/47_b24-00030/_article/-char/ja/ Laminin γ1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells Y Kuratomi, M Nomizu, K Tanaka, ML Ponce - British journal of , 2002 - nature.comhttps://www.nature.com/articles/6600187 Laminin-111-derived peptides and cancer Y Kikkawa , K Hozumi, F Katagiri, M Nomizu - Cell adhesion & , 2013 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/cam.22827 Maintenance of hepatic differentiation by hepatocyte attachment peptides derived from laminin chains Y Kikkawa , A Kataoka, Y Matsuda - Research Part A, 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jbm.a.33176 C16 peptide and Ang-1 improve functional disability and pathological changes in an Alzheimer's disease model associated with vascular dysfunction X Fu, J Wang, H Cai, H Jiang, S Han - Pharmaceuticals, 2022 - mdpi.comhttps://www.mdpi.com/1424-8247/15/4/471 The psoriasis therapeutic potential of a novel short laminin peptide C16 TC Ho, SI Yeh, SL Chen, YP Tsao - International Journal of Molecular , 2019 - mdpi.comhttps://www.mdpi.com/1422-0067/20/13/3144 Exploring bioactive peptides as potential therapeutic and biotechnology treasures: A contemporary perspective PJ Patil , SS Sutar , M Usman , DN Patil, MJ Dhanavade - Life Sciences, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S002432052200337X Peptide-chitosan engineered scaffolds for biomedical applications N Kulkarni , SD Shinde , GS Jadhav - Bioconjugate , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.1c00014 LAMININ DERIVED PEPTIDES: A PROMISING AND TISSUE-SPECIFIC APPROACH N Afrose, P Panja, S Dasgupta - researchgate.nethttps://www.researchgate.net/profile/Sandipan-Dasgupta-2/publication/357164189_LAMININ_DERIVED_PEPTIDES_A_PROMISING_AND_TISSUE-SPECIFIC_APPROACH/links/61bede4ca6251b553acc1f2c/LAMININ-DERIVED-PEPTIDES-A-PROMISING-AND-TISSUE-SPECIFIC-APPROACH.pdf Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth ML Ponce, S Hibino, AM Lebioda, M Mochizuki - Cancer research, 2003 - AACRhttps://aacrjournals.org/cancerres/article-abstract/63/16/5060/510257 Angiogenic activitiy of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT) M Mochizuki, D Philp, K Hozumi, N Suzuki - Archives of biochemistry , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003986106005029 Developing antiangiogenic peptide drugs for angiogenesis-related diseases KN Sulochana , R Ge - Current pharmaceutical design, 2007 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2007/00000013/00000020/art00005 The laminin alpha-1 chain derived peptide, AG73, increases fibronectin levels in breast and melanoma cancer cells JA Engbring, R Hossain, SJ VanOsdol - Clinical & Experimental , 2008 - Springerhttps://link.springer.com/article/10.1007/s10585-007-9138-y Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson's disease HY Cai, XX Fu, H Jiang, S Han - npj Parkinson's Disease, 2021 - nature.comhttps://www.nature.com/articles/s41531-021-00233-3 Effects of laminin-111 peptide coatings on rat neural stem/progenitor cell culture H Hayashi , I Horinokita, Y Yamada, K Hamada - Experimental Cell , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014482720306935 Angiopoietin-1 and alphaΜbeta3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex H Cai, K Tian, Y Zhang, H Jiang, S Han - Aging (Albany NY), 2018 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286852/ Assessment of bioactive peptides derived from laminin-111 as prospective breast cancer-targeting agents FF Mendonaca - Amino Acids, 2024 - Springerhttps://link.springer.com/article/10.1007/s00726-023-03379-x Delivery of theranostic nanoparticles to various cancers by means of integrin-binding peptides EA Egorova , MP Nikitin - International Journal of Molecular Sciences, 2022 - mdpi.comhttps://www.mdpi.com/1422-0067/23/22/13735 Laminin-111 peptide C16 regulates invadopodia activity of malignant cells through beta1 integrin, Src and ERK 1/2 AS Siqueira, MP Pinto, MC Cruz , B Smuczek - Oncotarget, 2016 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216987/

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP44225 H-KAFDITYVRLKF-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".